Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
OBX-115
i
Other names:
OBX-115, cytoTIL15, TIL armored/regulated membrane-bound IL15, novel engineered tumor infiltrating lymphocytes, TILs
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Obsidian, UT MD Anderson Cancer Center
Drug class:
IL-15 stimulant, T lymphocyte replacement
Related drugs:
‹
GTB-5550 (1)
CNTY-101 (0)
GEN-001 (0)
IAP0971 (0)
NKX019 (0)
SAL008 (0)
SIM0237 (0)
VG201 (0)
cam1615SS1 (0)
lifileucel (1)
ATL 001 (0)
BNT221 (0)
C-TCR055 (0)
CYAD-01 (0)
CoTIL-01 (0)
H3.3K27M TCR T cell therapy (0)
IOV-2001 (0)
NeoTCR-P1 (0)
RAPA-201 (0)
allodepleted T-cell immunotherapeutics (0)
ThisCART22 (0)
UTIL-01 (0)
anti-KRAS G12D mTCR PBL (0)
marrow infiltrating lymphocytes (0)
MT-401 (0)
GTB-5550 (1)
CNTY-101 (0)
GEN-001 (0)
IAP0971 (0)
NKX019 (0)
SAL008 (0)
SIM0237 (0)
VG201 (0)
cam1615SS1 (0)
lifileucel (1)
ATL 001 (0)
BNT221 (0)
C-TCR055 (0)
CYAD-01 (0)
CoTIL-01 (0)
H3.3K27M TCR T cell therapy (0)
IOV-2001 (0)
NeoTCR-P1 (0)
RAPA-201 (0)
allodepleted T-cell immunotherapeutics (0)
ThisCART22 (0)
UTIL-01 (0)
anti-KRAS G12D mTCR PBL (0)
marrow infiltrating lymphocytes (0)
MT-401 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login